There is “growing evidence” that weight-loss drugs could be effective in treating severely obese teenagers, an expert has said.
The medication acts “in exactly the same way” in younger patients as it does in adults, they claim, and while no evidence exists for use in patients under the age of 12, it “may be justified” in extreme cases.
The comments were made by Professor Louise Baur, an obesity paediatrician and professor of paediatrics at the University of Sydney in Australia, during a presentation at the International Congress on Obesity in Sao Paolo, Brazil.
Prof Baur, who is president of the World Obesity Federation, said: “Obesity among the youngest in our society is increasingly common.
“And just as we have realised with adults, obesity is not an acute-care, once-treated-always-cured disease.
“The use of the latest generation of obesity management medications could present a less invasive option for adolescents with more severe obesity.
“The evidence from various recent trials shows that these new medications, such as semaglutide, act in exactly the same way in adolescents as in adults, with a similar safety profile.
“One of the ways in which semaglutide works is by acting on brain appetite centres, promoting a sense of satiety, reducing hunger and encouraging a decrease in food consumption.”
Semaglutide – sold under the brand names Wegovy, Ozempic and Rybelsus – is a glucagon-like peptide-1 (GLP-1) agonist, a family of medications that help manage blood sugar.
Wegovy is recommended to help obese adults lose weight on the NHS by the National Institute for Health and Care Excellence (Nice).
Last year, NHS England revealed hospital admissions of obese youngsters under the age of 17 had tripled in a decade, growing from 3,370 in 2011/12 to 9,431 in 2021/22.
Globally, obesity rates among teenagers globally have quadrupled since 1990, according to the World Health Organisation (WHO).
Figures released in March showed there were more than 390 million overweight youngsters aged five to 19 in 2022, included 160 million who were classed as obese.
Prof Baur added: “There is a growing evidence base for some obesity management medications in adolescents – however no evidence exists yet for use in younger children aged under 12 years, but use may be justified in those younger children with more severe obesity.”
She warned that weight loss drugs must be combined with lifestyle changes “in all cases”.
“It is clear from our experience with adults that long-term use will most probably be needed, but further evidence is needed on this,” she said.
“More evidence is also needed for use of these medications in adolescents for maintenance therapy, pre-treatment for surgery, post-surgery treatment, combination therapy, and the use of medication with other obesity therapies.
“Yet as we have found with adults, the cost and availability of these medications are a major barrier in every country.”
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereLast Updated:
Report this comment Cancel